Herui Yao

13PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisInnate immunityGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 12, 2026
De-escalation of axillary surgery after neoadjuvant therapy in breast cancer: long-term outcomes of sentinel lymph node biopsy alone versus complete axillary lymph node dissection.

Haizhu Chen, Xiaoyan Qian, Luhui Mao

|Jan 02, 2025
Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: The Phase III MECCA Trial.

Ruo-Xi Hong, Fei Xu, Wen Xia

|Jun 20, 2024
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial.

Herui Yao, Min Yan, Zhongsheng Tong

|May 22, 2024
Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancer.

Jue Wang, Yunfang Yu, Yujie Tan

|Feb 09, 2023
Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics.

Yinghuan Cen, Letian Chen, Zihao Liu

|Aug 29, 2022
Machine Learning-Devised Immune-Related lncRNA Signature Panel Predicts the Prognosis and Immune Landscape in Breast Cancer Novel IRLP Signature in BRCA.

Jun-Yu Zhu, An-Qi Lyu, Zhang-Ting Wang

Pageof 3

Frequent Collaborators

2 joint publications

Erwei Song

2 joint publications

Qiang Liu

1 joint publications

Kai-Kei Miu

1 joint publications

Ruo-Xi Hong